Taihao Biotech
PrivateLast Round
Pre Seed
Jul 25, 2022
Company Overview
Taihao Biotech is a medical supplies company that develops point-of-care testing (POCT) systems designed for microfluidic molecular diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
point-of-care testingPOCTmolecular diagnosticsmicrofluidicsmicrofluidic chipslab-on-a-chipnucleic acid detectionin-vitro diagnosticsIVDrapid diagnosticsbiomolecular detectionbiotech equipmentmedical devicesanimal health diagnosticsenvironmental safety testing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Taihao Biotech Comps
Public and private peers based on sector, stage, and business model.
Taihao Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 25, 2022 |
Taihao Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Taihao Biotech's valuation, stock price, and market status.
